z-logo
Premium
A Cerberus‐Inspired Anti‐Infective Multicomponent Gatekeeper Hydrogel against Infections with the Emerging “Superbug” Yeast Candida auris
Author(s) -
Kubiczek Dennis,
Flaig Carolin,
Raber Heinz,
Dietz Steffen,
Kissmann AnnKathrin,
Heerde Thomas,
Bodenberger Nicholas,
Wittgens Andreas,
GonzálezGarcia Melaine,
Kang Fan,
Franco Octavio L.,
Staendker Ludger,
OteroGonzález Anselmo J.,
Walther Paul,
Gottschalk Kay E.,
Weil Tanja,
Rosenau Frank
Publication year - 2020
Publication title -
macromolecular bioscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 105
eISSN - 1616-5195
pISSN - 1616-5187
DOI - 10.1002/mabi.202000005
Subject(s) - candida auris , microbiology and biotechnology , antifungal , medicine , intensive care medicine , immunology , biology
The pathogenic yeast Candida auris has received increasing attention due to its ability to cause fatal infections, its resistance toward important fungicides, and its ability to persist on surfaces including medical devices in hospitals. To brace health care systems for this considerable risk, alternative therapeutic approaches such as antifungal peptides are urgently needed. In clinical wound care, a significant focus has been directed toward novel surgical (wound) dressings as first defense lines against C. auris . Inspired by Cerberus the Greek mythological “hound of Hades” that prevents the living from entering and the dead from leaving hell, the preparation of a gatekeeper hybrid hydrogel is reported featuring lectin‐mediated high‐affinity immobilization of C. auris cells from a collagen gel as a model substratum in combination with a release of an antifungal peptide drug to kill the trapped cells. The vision is an efficient and safe two‐layer medical composite hydrogel for the treatment of severe wound infections that typically occur in hospitals. Providing this new armament to the repertoire of possibilities for wound care in critical (intensive care) units may open new routes to shield and defend patients from infections and clinical facilities from spreading and invasion of C. auris and probably other fungal pathogens.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here